🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a observational study in patients treated with fesoterodine (Toviaz...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-07
Trial ID
NCT00691093
Treatments Being Tested
Radiation-induced cystitis is a condition commonly seen in patients who hav...
Status
Completed
Location
Ramathibodi Hospital
Start Date
2024-04-02
Trial ID
NCT07016451
Treatments Being Tested
The purpose of this study is to collect effectiveness and safety informatio...
Status
Completed
Location
Multiple Locations
Start Date
2013-10-01
Trial ID
NCT01936870
Treatments Being Tested
This is an open-label, randomized, two-way crossover study to evaluate the ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-07
Trial ID
NCT00914667
Treatments Being Tested
To evaluate the efficacy and safety of fesoterodine on overactive bladder s...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2007-11
Trial ID
NCT00546637
Treatments Being Tested
This study is being done to evaluate the use of a new technology (urine pro...
Status
Completed
Location
Washington University School of Medicine
Start Date
2010-08
Trial ID
NCT01367886
Treatments Being Tested
Parkinson's disease (PD) causes several non-motor autonomic symptoms includ...
Status
Terminated
Location
Jewish General Hospital
Start Date
2016-09
Trial ID
NCT02385500
Treatments Being Tested
Collect information on treatment with Toviaz (fesoterodine) under ordinary ...
Status
Terminated
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01091519
To assess the effect of fesoterodine 8 mg as compared to solifenacin 10 mg ...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2009-04
Trial ID
NCT00832650
Treatments Being Tested
This extension trial of SP668 consists of two phases: double-blind treatmen...
Status
Completed
Location
Schwarz
Start Date
2003-06
Trial ID
NCT00220389
Treatments Being Tested